The TENET i2c program facilitates the translation of medical research and discovery into product development and company creation. The program awards up to $100K to one team per year to support commercialization goals. Teams of all maturity levels, whether in concept development or in revenue, are welcome to apply. Pitch and business training is provided to all short-listed companies. This year’s TENET i2c Final Pitch Event will be held at Western Canada’s most innovative platform — INVENTURE$ Conference — on June 7, 2019.